Biphasic modulation of synaptic transmission by hypertonicity at the embryonic Drosophila neuromuscular junction.
Puff-application of hypertonic saline (sucrose added to external saline) causes a transient increase in the frequency of spontaneous miniature synaptic currents (mSCs) at the neuromuscular junctions of Drosophila embryos. The frequency gradually returns to pre-application levels. External Ca(2+) is not needed for this response, but it may modify it. At 50 mM added sucrose, for example, enhanced spontaneous release was observed only in the presence of external Ca(2+), suggesting that Ca(2+) augments the response. In a high-K(+) solution, in which the basal mSC frequency was elevated, higher sucrose concentrations produced an increase in mSC frequency that was followed (during and after the hypertonic exposure) by depression, with the magnitude of both effects increasing with hypertonicity between 100 and 500 mM. Evoked release by nerve stimulation showed only depression in response to hypertonicity. We do not believe that the depression of spontaneous or evoked release can be explained by the depletion of releasable quanta, however, since the frequency of quantal release did not reach levels compatible with this explanation and the enhancement and depression could be obtained independent of one another. In a mutant lacking neuronal synaptobrevin, only the depression of mSC frequency was induced by hypertonicity. Conversely, only the enhancing effect was observed in wild-type embryos when the mSC frequency was elevated with forskolin in Ca(2+)-free saline. In cultured embryonic Drosophila neurons, Ca(2+) signals that were induced by high K(+) and detected by Fura-2, were reduced by hypertonicity, suggesting that the depressing response is due to a direct effect of hypertonicity on Ca(2+) influx.
Suzuki
Kazuhiro
K
Institute for Behavioral Sciences, Gunma University School of Medicine, 3-39-22 Showa-machi, Maebashi 371-8511, Japan.
Okamoto
Tomonori
T
Kidokoro
Yoshiaki
Y
D000818:Animals; D002118:Calcium / Q000378:metabolism / Q000494:pharmacology; D002478:Cells, Cultured; D005576:Colforsin / Q000494:pharmacology; D004330:Drosophila / Q000196:embryology*; D029721:Drosophila Proteins; D004338:Drug Combinations; D004625:Embryo, Nonmammalian / Q000502:physiology; D006982:Hypertonic Solutions / Q000494:pharmacology; D019476:Insect Proteins / Q000235:genetics; D007425:Intracellular Membranes / Q000378:metabolism; D009154:Mutation / Q000502:physiology; D009469:Neuromuscular Junction / Q000196:embryology*; D009474:Neurons / Q000378:metabolism; D009479:Neuropeptides / Q000235:genetics; D018377:Neurotransmitter Agents / Q000378:metabolism; D009842:Oligopeptides / Q000494:pharmacology; D011188:Potassium / Q000494:pharmacology; D050683:R-SNARE Proteins; D009435:Synaptic Transmission / Q000187:drug effects / Q000502:physiology*; D033921:Vesicular Transport Proteins
D029721:Drosophila Proteins; D004338:Drug Combinations; D006982:Hypertonic Solutions; D019476:Insect Proteins; D009479:Neuropeptides; D018377:Neurotransmitter Agents; D009842:Oligopeptides; D050683:R-SNARE Proteins; D033921:Vesicular Transport Proteins; C084068:nsyb protein, Drosophila; D005576:Colforsin; C047981:arginyl-glycyl-aspartic acid; D011188:Potassium; D002118:Calcium